Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (181-190 of 221) with videos related to

Pageof 23
Sort By:
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2007
Standard operating procedure for the collection of fresh frozen tissue samplesS R Mager, M H A Oomen, M M Morente, et al.
British Journal of Cancer|July 1, 1991
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastasesJ A Goldberg, J A Thomson, M S Bradnam, et al.
Cancer Research|December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acidD J Kerr, S B Kaye, J Cassidy, et al.
Cell Death and Differentiation|February 23, 2002
Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cellsA E Milner, D H Palmer, E A Hodgkin, et al.
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Lancet (London, England)|February 14, 2003
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trialG C Wishart, D Bissett, J Paul, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
Cancer Research|June 1, 1986
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)D J Kerr, S B Kaye, J Graham, et al.
Pageof 23

Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2007
Standard operating procedure for the collection of fresh frozen tissue samplesS R Mager, M H A Oomen, M M Morente, et al.
British Journal of Cancer|July 1, 1991
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastasesJ A Goldberg, J A Thomson, M S Bradnam, et al.
Cancer Research|December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acidD J Kerr, S B Kaye, J Cassidy, et al.
Cell Death and Differentiation|February 23, 2002
Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cellsA E Milner, D H Palmer, E A Hodgkin, et al.
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Lancet (London, England)|February 14, 2003
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trialG C Wishart, D Bissett, J Paul, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
Cancer Research|June 1, 1986
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)D J Kerr, S B Kaye, J Graham, et al.
Pageof 23